loadpatents
name:-0.019192934036255
name:-0.0024478435516357
name:-0.0043368339538574
VERWIJS; Marinus Jacobus Patent Filings

VERWIJS; Marinus Jacobus

Patent Applications and Registrations

Patent applications and USPTO patent grants for VERWIJS; Marinus Jacobus.The latest application filed is for "pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof".

Company Profile
5.6.29
  • VERWIJS; Marinus Jacobus - Framingham MA
  • VERWIJS; Marinus Jacobus - Sudbury MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl) Benzoic Acid And Administration Thereof
App 20220031679 - VERWIJS; Marinus Jacobus ;   et al.
2022-02-03
Crystalline Compounds And Methods Of Making The Same
App 20210221800 - VERWIJS; Marinus Jacobus ;   et al.
2021-07-22
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof
Grant 11,052,075 - Verwijs , et al. July 6, 2
2021-07-06
Pharmaceutical Composition And Administrations Thereof
App 20210023070 - Rowe; William ;   et al.
2021-01-28
Pharmaceutical Compositions For The Treatment Of Cftr Mediated Diseases
App 20200338063 - VERWIJS; Marinus Jacobus ;   et al.
2020-10-29
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl) Ben
App 20200197380 - Verwijs; Marinus Jacobus ;   et al.
2020-06-25
Pharmaceutical composition and administrations thereof
Grant 10,646,481 - Rowe , et al.
2020-05-12
Formulations Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic Acid
App 20200085750 - Verwijs; Marinus Jacobus
2020-03-19
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl) Benzoic Acid And Administration Thereof
App 20190070155 - VERWIJS; Marinus Jacobus ;   et al.
2019-03-07
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof
Grant 10,076,513 - Verwijs , et al. September 18, 2
2018-09-18
Formulations Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic Acid
App 20180008546 - Verwijs; Marinus Jacobus
2018-01-11
Pharmaceutical Composition And Administrations Thereof
App 20170087144 - ROWE; WIlliam ;   et al.
2017-03-30
Pharmaceutical Compositions for the Treatment of CFTR Mediated Diseases
App 20160324846 - Verwijs; Marinus Jacobus ;   et al.
2016-11-10
Formulations Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic Acid
App 20160324788 - Verwijs; Marinus Jacobus
2016-11-10
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl) Benzoic Acid And Administration Thereof.
App 20160303096 - VERWIJS; MARINUS JACOBUS ;   et al.
2016-10-20
Pharmaceutical Compositions and Administrations Thereof
App 20160022665 - Van Goor; Fredrick F. ;   et al.
2016-01-28
Pharmaceutical Compositions and Administrations Thereof
App 20160022664 - Van Goor; Fredrick F. ;   et al.
2016-01-28
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
Grant 9,241,934 - Verwijs , et al. January 26, 2
2016-01-26
Pharmaceutical Compositions and Administrations Thereof
App 20150164881 - Van Goor; Fredrick F. ;   et al.
2015-06-18
Pharmaceutical Compositions And Administrations Thereof
App 20150164883 - Van Goor; Fredrick F. ;   et al.
2015-06-18
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic Acid And Administration Thereof
App 20150140094 - Verwijs; Marinus Jacobus ;   et al.
2015-05-21
Pharmaceutical Composition and Administrations Thereof
App 20140315948 - Rowe; William ;   et al.
2014-10-23
Pharmaceutical Compositions for the Treatment of CFTR Mediated Diseases
App 20140163068 - Verwijs; Marinus Jacobus ;   et al.
2014-06-12
Pharmaceutical Composition and Administrations Thereof
App 20140112988 - Rowe; William ;   et al.
2014-04-24
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic Acid And Administration Thereof
App 20140023706 - Verwijs; Marinus Jacobus ;   et al.
2014-01-23
Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
Grant 8,552,034 - Verwijs , et al. October 8, 2
2013-10-08
Pharmaceutical Compositions And Administrations Thereof
App 20130158071 - Van Goor; Fredrick F. ;   et al.
2013-06-20
Pharmaceutical Compositions And Administrations Thereof
App 20130131107 - Van Goor; Fredrick F. ;   et al.
2013-05-23
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic Acid And Administration Thereof
App 20130095181 - Verwijs; Marinus Jacobus ;   et al.
2013-04-18
Pharmaceutical Composition and Administrations Thereof
App 20120258983 - Rowe; William ;   et al.
2012-10-11
Pharmaceutical Composition And Administrations Thereof
App 20120220625 - Rowe; William ;   et al.
2012-08-30
Pharmaceutical Compositions Of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) Cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic Acid And Administration Thereof
App 20110256220 - Verwijs; Marinus Jacobus ;   et al.
2011-10-20
Pharmaceutical Composition And Administrations Thereof
App 20100256184 - Rowe; William ;   et al.
2010-10-07
Pharmaceutical composition and administration thereof
App 20100074949 - Rowe; William ;   et al.
2010-03-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed